关于：“绝经后激素联合治疗与心血管疾病：致力于解决观察性研究与妇女健康倡议临床试验之间的差异” - Suppr

Suppr

超能文献

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".

作者信息

Willett Walter C, Manson JoAnn E, Grodstein Francine, Stampfer Meir J, Colditz Graham A

出版信息

Am J Epidemiol. 2006 Jun 1;163(11):1067-8; author reply 1068-9. doi: 10.1093/aje/kwj156. Epub 2006 Apr 26.

DOI:10.1093/aje/kwj156

PMID:16641306

Abstract

摘要

相似文献

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial".

Am J Epidemiol. 2006 Jun 1;163(11):1067-8; author reply 1068-9. doi: 10.1093/aje/kwj156. Epub 2006 Apr 26.

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Am J Epidemiol. 2005 Sep 1;162(5):404-14. doi: 10.1093/aje/kwi223. Epub 2005 Jul 20.

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Am J Epidemiol. 2006 Apr 1;163(7):589-99. doi: 10.1093/aje/kwj079. Epub 2006 Feb 16.

Invited commentary: how far can epidemiologists get with statistical adjustment?

Am J Epidemiol. 2005 Sep 1;162(5):415-8; discussion 419-20. doi: 10.1093/aje/kwi224. Epub 2005 Jul 13.

Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.

Climacteric. 2006 Dec;9(6):416-20. doi: 10.1080/13697130601012061.

The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.

J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S3-5.

Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.

Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):123-4. doi: 10.1016/s0301-2115(02)00413-x.

The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.

Gynecol Endocrinol. 2006 Jun;22(6):303-17. doi: 10.1080/09513590600717368.

Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.

Medscape Womens Health. 2002 Jul-Aug;7(4):8.

Lung cancer and hormone replacement therapy.

Lancet. 2010 Jan 9;375(9709):117; author reply 118-9. doi: 10.1016/S0140-6736(10)60039-6.

引用本文的文献

Hormone Therapy Use and Risk of Chronic Disease in the Nurses' Health Study: A Comparative Analysis With the Women's Health Initiative.

Am J Epidemiol. 2017 Sep 15;186(6):696-708. doi: 10.1093/aje/kwx131.

Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study.

Menopause. 2011 Mar;18(3):253-61. doi: 10.1097/gme.0b013e3181f0839a.

Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.

Circulation. 2009 Feb 24;119(7):922-30. doi: 10.1161/CIRCULATIONAHA.108.817577. Epub 2009 Feb 9.

Dose-dependent cardiac effect of oestrogen replacement in mice post-myocardial infarction.

Exp Physiol. 2008 Aug;93(8):982-93. doi: 10.1113/expphysiol.2008.042788. Epub 2008 May 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验